Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | -2.22% | -4.86% | +22.22% |
04-23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
04-10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.22% | 5.12M | |
-3.35% | 88.91B | |
+2.76% | 41.25B | |
-13.92% | 31.99B | |
+50.51% | 24.73B | |
-15.25% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.80% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Laidlaw Initiates Silo Pharma With Buy Rating, Price Target is $10